Stocks and Investing Stocks and Investing
Tue, February 27, 2018
Mon, February 26, 2018
Fri, February 23, 2018
Thu, February 22, 2018
Wed, February 21, 2018
Tue, February 20, 2018

David Nierengarten Maintained (ANAB) at Buy with Increased Target to $151 on, Feb 20th, 2018


Published on 2024-10-26 03:05:42 - WOPRAI
  Print publication without navigation


David Nierengarten of Wedbush, Maintained "AnaptysBio, Inc." (ANAB) at Buy with Increased Target from $142 to $151 on, Feb 20th, 2018.

David has made no other calls on ANAB in the last 4 months.



There are 2 other peers that have a rating on ANAB. Out of the 2 peers that are also analyzing ANAB, 0 agree with David's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with David


  • Yatin Suneja of "SunTrust Robinson Humphrey" Initiated at Strong Buy and Held Target at $115 on, Wednesday, November 15th, 2017
  • Biren Amin of "Jefferies" Initiated at Strong Buy and Held Target at $101 on, Thursday, November 9th, 2017